Malathi, Divyashanthi Chellathambi, Kumaravel Janakiraman, Sathiya Vinotha Ariyur Thangavelu, and Dhivya Ravichandran. “Enlicitide (Lipfendra): The First Oral PCSK9 Inhibitor - from Macrocyclic Peptide Innovation to Clinical Translation”. International Journal of Basic & Clinical Pharmacology 15, no. 5 (August 24, 2026): 1126–1134. Accessed August 25, 2026. https://www.ijbcp.com/index.php/ijbcp/article/view/6446.